Episode
The One Rule That Made Global Trade in Generic Drugs Possible
- Published
- Jul 14, 2026
- Duration seconds
- 692
- Processing state
not_requested- Canonical source
- https://audio.fexingo.com/business/global-trade/episode-0110.mp3
Actions
POST https://stenobird.com/v1/public/podcasts/global-trade-with-fexingo-wto-free-trade-agreements-and-international-commerce-7871813/episodes/the-one-rule-that-made-global-trade-in-generic-drugs-possible/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/global-trade-with-fexingo-wto-free-trade-agreements-and-international-commerce-7871813/the-one-rule-that-made-global-trade-in-generic-drugs-possible.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Episode 110 of Global Trade with Fexingo digs into the single WTO rule that unlocked cross-border trade in generic pharmaceuticals: the 2005 amendment to the TRIPS Agreement that created a compulsory licensing pathway for export. Lucas walks through the decade-long negotiation between big pharma, developing nations, and public health advocates that produced the paragraph 6 system. Luna asks why only one country has ever used it — Rwanda, in 2007, to import HIV drugs from Canada. They explore the practical hurdles: manufacturing complexity, regulatory approval, political pressure. The episode closes on a forward-looking note about the WTO's ongoing waiver debate for COVID-19 vaccines and treatments, asking whether the system is broken or just barely good enough. A concrete, numbers-driven look at how intellectual property rules shape who gets medicine and who doesn't. Recorded July 14, 2026. #WTO #TRIPS #GenericDrugs #Pharmaceuticals #CompulsoryLicensing #Rwanda #Canada #HIV #PublicHealth #IntellectualProperty #GlobalTrade #Paragraph6 #DohaDeclaration #COVID19 #VaccineWaiver #Economics #FexingoBusiness #BusinessPodcast Keep every episode free: buymeacoffee.com/fexingo